← Evidence map

ReviewDrug design, development and therapy2024

Profile of Ofatumumab in the Treatment of Multiple Sclerosis: Design, Development and Place in Therapy.

Zeinab Awada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39687682